Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion
| Autor: | Nieves Gutiérrez-Zufiaurre, Lourdes Lopez, José Ángel García Rodríguez, Francisco González San Martín, Rosa Pérez-Grande, Juan Luis Muñoz Bellido, Ana Blázquez de Castro, Santiago Muñoz-Criado |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
Adult
Microbiology (medical) HBsAg Biology medicine.disease_cause Antiviral Agents Orthohepadnavirus medicine Humans Hepatitis B Antibodies Seroconversion Bone Marrow Transplantation Hepatitis B virus Hepatitis B Surface Antigens Reverse-transcriptase inhibitor virus diseases Lamivudine General Medicine Hepatitis B biology.organism_classification medicine.disease digestive system diseases Infectious Diseases Hepadnaviridae Immunology Female Immunosuppressive Agents medicine.drug |
| Zdroj: | Diagnostic Microbiology and Infectious Disease. 64:80-82 |
| ISSN: | 0732-8893 |
| DOI: | 10.1016/j.diagmicrobio.2009.01.007 |
| Popis: | Hepatitis B reactivation in hepatitis B surface antigen (HBsAg)-negative and anti-HBsAg antibodies-positive patients is an infrequent complication of chemotherapy, usually with fatal evolution. Here we report an HBsAg-negative patient with a myelodysplastic syndrome, who developed hepatitis B reactivation after chemotherapy and evolved favorably after lamivudine treatment, allowing seroconversion. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect